- All sections
- C - Chemistrymetallurgy
- C07D - Heterocyclic compounds
- C07D 267/14 - Seven-membered rings having the hetero atoms in positions 1 and 4 condensed with carbocyclic rings or ring systems condensed with one six-membered ring
Patent holdings for IPC class C07D 267/14
Total number of patents in this class: 183
10-year publication summary
16
|
7
|
12
|
28
|
14
|
17
|
9
|
15
|
6
|
7
|
2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
Principal owners for this class
Owner |
All patents
|
This class
|
---|---|---|
VALO Health, Inc. | 172 |
34 |
Glaxosmithkline Intellectual Property Development Limited | 762 |
12 |
Rigel Pharmaceuticals, Inc. | 538 |
11 |
Denali Therapeutics Inc. | 246 |
9 |
Gilead Sciences, Inc. | 2032 |
8 |
Shanghai Zhimeng Biopharma Inc. | 33 |
6 |
Genentech, Inc. | 3976 |
5 |
Astex Therapeutics Limited | 239 |
5 |
Constellation Pharmaceuticals, Inc. | 213 |
5 |
Shionogi & Co., Ltd. | 852 |
4 |
F. Hoffmann-La Roche AG | 7947 |
3 |
Board of Regents, The University of Texas System | 5808 |
3 |
Takeda Pharmaceutical Company Limited | 2708 |
3 |
BP Oil International Limited | 77 |
3 |
Cocrystal Pharma, Inc. | 46 |
3 |
USA Elixiria Biotech Inc | 3 |
3 |
Hoffmann-La Roche Inc. | 3439 |
2 |
The Regents of the University of California | 19961 |
2 |
Boehringer Ingelheim International GmbH | 4642 |
2 |
Japan Tobacco Inc. | 3596 |
2 |
Other owners | 58 |